Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
Coronary artery disease
Intravascular imaging
Lipid core burden index
Lipid-rich plaque
Plaque burden
Journal
International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
received:
07
12
2021
revised:
21
06
2022
accepted:
12
07
2022
pubmed:
17
7
2022
medline:
14
9
2022
entrez:
16
7
2022
Statut:
ppublish
Résumé
Large plaque burden (PB) has been linked to adverse coronary events. We sought to assess the correlation between lipidic content and arterial PB within the Lipid Rich Plaque (LRP) study. This analysis included 1269 patients and 5743 coronary segments with both evaluable Lipid Core Burden Index (maxLCBI NC-MACE for segment cohorts in the most vulnerable quadrant of maxLCBI Coronary segments with high lipid content but no measurable PB were still associated with events at 2 years. NC-MACE vulnerability increased as the lipidic content and PB increased, with the highest incidence within segments having maxLCBI The Lipid-Rich Plaque Study (LRP), NCT02033694, https://clinicaltrials.gov/ct2/show/NCT02033694.
Sections du résumé
BACKGROUND
Large plaque burden (PB) has been linked to adverse coronary events. We sought to assess the correlation between lipidic content and arterial PB within the Lipid Rich Plaque (LRP) study.
METHODS
This analysis included 1269 patients and 5743 coronary segments with both evaluable Lipid Core Burden Index (maxLCBI
RESULTS
NC-MACE for segment cohorts in the most vulnerable quadrant of maxLCBI
CONCLUSIONS
Coronary segments with high lipid content but no measurable PB were still associated with events at 2 years. NC-MACE vulnerability increased as the lipidic content and PB increased, with the highest incidence within segments having maxLCBI
CLINICAL TRIAL REGISTRATION
The Lipid-Rich Plaque Study (LRP), NCT02033694, https://clinicaltrials.gov/ct2/show/NCT02033694.
Identifiants
pubmed: 35842005
pii: S0167-5273(22)01092-0
doi: 10.1016/j.ijcard.2022.07.024
pii:
doi:
Substances chimiques
Lipids
0
Banques de données
ClinicalTrials.gov
['NCT02033694']
Types de publication
Clinical Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32-34Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.